Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The proto-oncogene protein c-mas-1 receptor, commonly referred to as MAS1, is a G protein-coupled receptor (GPCR) encoded by the MAS1 gene in humans. It is characterized by a seven-transmembrane domain structure typical of GPCRs and plays significant roles in cellular signaling pathways related to growth regulation, cardiovascular function, and inflammation. It acts primarily as a receptor for angiotensin-(1–7), a peptide hormone within the renin–angiotensin system (RAS). Upon activation by its ligand Ang-(1–7), the MAS1 receptor modulates several physiological processes including vasodilation, angiogenesis, antifibrotic and antihypertrophic effects.
Agonist of MAS1 receptor leading to vasodilation, angiogenesis, and anti-inflammatory effects. Antagonists block these actions.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene protein c-mas-1 receptor (MAS1).